Category Archives: Featured

Community, Conversations, Featured, Patient Centric, Regulatory, Technical

Microsampling: Why Can’t a Human Serve as Their Own Control?

Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)

Pre-Conference Workshop – Microsampling

Sponsored by New Objective

Kevin Bateman, Merck

“The sharing part is important, it motivates others to do the same” – Kevin Bateman, Merck

The microsampling community continues to improve technologies and solutions for the patient, while working towards understanding human biology.  During Kevin’s CPSA Everyday, Microsampling edition, he describes a Vison that is dedicated to motivating others to engage in microsampling – in a collaborative way.  While working through the complexity of iterative loops for development of technology to solutions (from a perceived failure, to understanding, to improving the science or process) we can work together with each other’s expertise, for the patient.  Each human is different, and such: Why can’t each human be their own control?  Starting from a heal prick at birth, can we simply have more data points?  Kevin discusses a Vision that also speaks towards patient adherence and regulatory aspects for implementing micosampling solutions. In the end, improving healthcare is not a competition, it is actually a team sport.

Community, Conversations, Disease, Featured, Integrative Omics, Patient Centric

Considerations from the Frontline for Infectious Disease – COVID-19 Pandemic

7th Annual Brasilian Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA BRASIL 2020)

Program Chair – CPSA Brazil 2020
Carlos Kiffer, MD, Ph.D. from Escola Paulista de Medicina / Universidade Federal de São Paulo

“We’re responsible for ourselves as much as we are responsible for our communities.”

“(What COVID-19 brought us) A chance of observing a large number of patients over a small period of time. You start to see patterns.”

“I wish everyone could take care of each other.”

Diseases are complex, and the COVID-19 pandemic presents with several manifestations.  Working in infectious disease for over 30 years, Carlos has observed 100’s to 1000’s of patients and works with friends and colleagues to identify patterns related to these different manifestations.  They work together to make sense of these patterns through observations of patients in the hospitals, as well as using metabolomics, proteomics, and genetics to measure molecular differences in manifestations.  The global pandemic will bring changes to certain approaches used for understanding infectious disease, and Carlos passionately works with community to bring relevant knowledge to design clinical scoring systems to define the spectrum of COVID-19 manifestations.

Clinical, Conversations, Education, Featured, Metabolomics, Patient Centric

Considerations on Metabolomics and Integrative Omics – COVID-19 Response and Post Recovry Diseases

7th Annual Brasilian Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA BRASIL 2020)

Roundtable Session Coordinator – CPSA Brazil 2020
Regina Oliveira, Ph.D. from Universidade Federal de São Carlos

“My passion is to know that I can make a difference.”

“[Make the general public] feel more comfortable knowing that it will pass, and that science will help them find the solution, to take away from health problem”

“Need to think about the disease (COVID-19) after recovery.”

In a response to a pandemic such as COVID-19, Regina looks to not only collect relevant data from patient samples – she also educates her family, friends, and community that we will get through this crisis together. Along with education with generating accurate knowledge, her lab (among many projects) works on diseases related to COVID-19 that appear months to years after the infection and recovery. The knowledge is created through clinical research with metabolomics – a technology that has been on the front line for COVID-19 patients that present other diseases post recovery. Although complex in nature, Regina creates understandable biological knowledge that is helping patients – and can be shared with the population as a whole.

Roundtable Session – Lead by Regina Oliveira, Ph.D

Gustavo Simões, CEO Nanox, São Carlos, São Paulo, Brazil

Markus Schreyer, CEO & Founder, Ganeshalab

Valdemir Carvalho, Ph,D, Senior Scientific Consultant at Fleury Group, São Paulo, Brazil

Roundtable Contributors
Gustavo Mendes Lima Santos
Carlos Kiffer, MD, Ph.D.
Marc Chalom